1. Johnson E, Salari K, Yang S. SETDB1: a perspective into immune cell function and cancer immunotherapy. Immunology. 2022 Dec 16, Online ahead of print. PMID: 36524435.
  2. Li Y, Zhou W, Li L, Li J, Li T, Huang C, Lazaro-Camp VJ, Kavlashvili T, Zhang Y, Reyes H, Li Y, Dai D, Zhu W, Meng X, Leslie KK, Yang S.  Enhancing progestin therapy via HDAC inhibitors in endometrial cancer. Am J Cancer Res. 2022 Nov 15;12(11):5029. PMID: 36504895, PMCID: PMC9729913.
  3. Li Y, Zhou W, Meng X, Murray SD, Li L, Fronk A, Lazaro-Camp VJ, Wen KK, Wu M, Dupuy A, Leslie KK, Yang S.  Utilizing an endogenous progesterone receptor reporter gene for drug screening and mechanistic study in endometrial cancer, Cancers (Basel). 2022 Oct 6;14(19):4883. PMID: 36230806, PMCID: PMC9561963.
  4. Lazaro-Camp VJ, Salari K, Meng X, Yang S. SETDB1 in cancer: overexpression and its therapeutic implications. Am J Cancer Res. 2021 May 15;11(5):1803-1827. eCollection 2021. PMID: 34094655